Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
J INTS BIO Presents Interim Results from the Preclinical Study of 'JIN-001' in Refractory Ovarian Cancer: A Promising Solution for Overcoming Drug Resistance 2024-10-24 10:45
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance 2024-10-23 21:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 20:00
Doceree forms Strategic Partnership with The Ward Marketing Group to Strengthen Its Global Footprint; Expands into Australian Market 2024-10-23 19:05
Samsung Biologics reports third quarter 2024 financial results 2024-10-23 14:55
Halloween 2024: Wisesky Drives New Trend of Healthy Living with Early Bird Black Friday Deal on Its Advanced W-Cat Air Purifier Designed Specifically for Cats 2024-10-23 14:53
Nisun International Enters Strategic Partnership with Beijing Tong Ren Tang to Source Traditional Chinese Medicine Ingredients 2024-10-22 21:29
Bloomage 'YunZhong (In Cloud) Public Welfare' Campaign: A 14-Year Journey of Cultural Preservation and Sustainability 2024-10-22 21:00
Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED) 2024-10-22 18:00
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure 2024-10-22 13:47
South Korean Mental Tech Startup DoctorPresso Publishes Study to Detect Depression from User-Generated Diary test data in International Journal 2024-10-22 09:08
A Comprehensive Introduction of the oneClick+ antigen platform 2024-10-22 03:00
Datasea Announces the Closing of a $4.0 Million Private Offering, Primarily Funded by the Company's CEO and Director 2024-10-21 21:30
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies 2024-10-21 19:30
Mediso introduces true theranostic TheraMAX SPECT/CT 2024-10-21 16:00
Great Bay Bio Intelligent Drug Development Ecosystem Officially Launched 2024-10-21 13:57
MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum 2024-10-18 22:09
Neurophet to host Symposium featuring renowned expert in Alzheimer's disease treatment from the U.S. 2024-10-18 21:00
LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing 2024-10-18 18:00
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow 2024-10-18 17:00
1 13 14 15 16 17 807